Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
Clinical trial NCT02285777 · COMPLETED
Trial details
- NCT number
- NCT02285777
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-03-26
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.